WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002032445) INHIBITION OF THE INTERACTION BETWEEN OXIDIZED PROTEINS AND CD36 OR THE ACTIVE MECHANISM THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/032445    International Application No.:    PCT/EP2001/012129
Publication Date: 25.04.2002 International Filing Date: 19.10.2001
Chapter 2 Demand Filed:    07.05.2002    
IPC:
A61K 38/17 (2006.01), C07K 16/28 (2006.01)
Applicants: KEHREL, Beate [DE/DE]; (DE).
BRODDE, Martin [DE/DE]; (DE) (For US Only)
Inventors: KEHREL, Beate; (DE).
BRODDE, Martin; (DE)
Agent: WEICKMANN & WEICKMANN; Postfach 860 820 81635 München (DE)
Priority Data:
100 51 983.0 20.10.2000 DE
101 48 624.3 02.10.2001 DE
Title (DE) HEMMUNG DER INTERAKTION ZWISCHEN OXIDIERTE PROTEINE UND CD36 ODER DESSEN WIRKMECHANISMUS
(EN) INHIBITION OF THE INTERACTION BETWEEN OXIDIZED PROTEINS AND CD36 OR THE ACTIVE MECHANISM THEREOF
(FR) PROTEINES OXYDEES, LEUR EFFET BIOLOGIQUE ET MESURES THERAPEUTIQUES ET DIAGNOSTIQUES DECOULANT DU MECANISME D'ACTION, DE L'UTILISATION DE CES PROTEINES OU DE LEUR INHIBITION
Abstract: front page image
(DE)Die vorliegende Erfindung betrifft Substanzen, die die Bindung von oxidierten Proteinen an CD36 oder die durch Interaktion von CD36 mit oxidierten Proteinen induzierten Funktionen von CD36 hemmen und ihre Verwendung als Arzneimittel für Menschen und Tiere.
(EN)The invention relates to substances, which inhibit the binding of oxidized proteins to CD36 or inhibit the functions of CD36 that are induced by the interaction of CD36 with oxidized proteins. The invention also relates to the use of these substances as medicaments for humans and animals.
(FR)L'invention concerne des substances inhibant la fixation de protéines oxydées sur le CD36 ou les fonctions induites par interaction du CD36 avec des protéines oxydées, ainsi que leur utilisation comme médicament pour l'homme ou l'animal.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: German (DE)
Filing Language: German (DE)